Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 07, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
Journal: Cancer
Published: March 21, 2026
Delta-Like Ligand 3 Expression by Immunohistochemistry in Rare Neuroendocrine Neoplasms and Associated Response to Off-Label Tarlatamab Treatment.
Journal: JCO precision oncology
Published: January 23, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignancies.
Journal: Journal of the National Cancer Institute
Published: January 22, 2026
Determination of HU override for gold fiducial markers in proton therapy.
Journal: Journal of applied clinical medical physics
Published: January 22, 2026
Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax® on Fatty Acid Synthesis in Prostate Cancer.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: November 19, 2025
Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: April 08, 2025
Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.
Journal: International journal of radiation oncology, biology, physics
Published: March 31, 2025
Transplant-Free Salvage of Relapsed/Refractory Classic Hodgkin Lymphoma in Children, Adolescents, and Young Adults: An Emerging Role for Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: February 12, 2025
Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis.
Journal: Experimental hematology & oncology
Published: January 16, 2025
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: September 18, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Journal: The New England journal of medicine
Published: September 16, 2024
Last Updated: 09/26/2026